Major Drug Interaction

Can You Take Mirtazapine with Clonazepam?

A plain-English look at the major interaction between Mirtazapine (MIRTANZA ODT) and Clonazepam (Rivotril) — what it means, why it happens, and what to talk to your doctor or pharmacist about.

Reviewed by , Registered Pharmacist
Last reviewed: How we research and review
Major severity AllMeds interaction database

Taking Mirtazapine (MIRTANZA ODT) with Clonazepam (Rivotril) is a major drug interaction that should be avoided. Life-threatening respiratory depression, overdose, coma, and death. Additive CNS and respiratory depression. Both drug classes suppress breathing through different mechanisms, creating synergistic respiratory depression that can be fatal.

Not sure about your specific combination? Check it in the Drug Interaction Checker →

Key Takeaways

  • Interaction severity: Major
  • Risk: Life-threatening respiratory depression, overdose, coma, and death.
  • Mechanism: Additive CNS and respiratory depression. Both drug classes suppress breathing through different mechanisms, creating synergistic respiratory depression that can be fatal.
  • Mirtazapine: S4 in Australia, low risk
  • Clonazepam: S4 in Australia, moderate risk
  • Claims action: Flag for immediate prescriber review. Document intervention in claim file.

Mirtazapine vs Clonazepam at a Glance

Property Mirtazapine Clonazepam
Brand names MIRTANZA ODT, Avanza, Axit 30 Rivotril, Paxam 0.5, Paxam 2
Drug class opioid benzo
Risk level low moderate
TGA Schedule (AU) S4 S4

Why Is This Combination Dangerous?

Additive CNS and respiratory depression. Both drug classes suppress breathing through different mechanisms, creating synergistic respiratory depression that can be fatal.

Clinical risk: Life-threatening respiratory depression, overdose, coma, and death.

Regulatory Guidance by Jurisdiction

Australia TGA / SIRA / WorkSafe

The TGA and Australian Medicines Handbook classify this as a major drug interaction requiring immediate intervention.

All Australian state workers compensation schemes (SIRA NSW, WorkSafe VIC, WorkCover QLD) flag concurrent opioid and benzodiazepine prescribing as high-risk. SIRA best practice guidelines explicitly recommend avoiding this combination except in exceptional circumstances with specialist oversight.

United Kingdom NICE / MHRA / FPM

NICE NG193 (Chronic Pain) recommends against initiating opioids for chronic primary pain. The Faculty of Pain Medicine (FPM) Opioids Aware guidelines strongly advise against concurrent opioid and benzodiazepine prescribing. For personal injury claims in the UK, this combination should be flagged for specialist review. Costs for medication review may be recoverable as a disbursement.

United States FDA / CDC / State WC

The FDA requires a Boxed Warning on all opioid and benzodiazepine products about the risks of concurrent use. The CDC Clinical Practice Guideline (2022) recommends clinicians avoid prescribing opioids and benzodiazepines concurrently whenever possible. Most state workers compensation drug formularies flag or restrict this combination.

What Claims Professionals Should Do

  1. Flag immediately as a high-risk prescribing pattern in the claim file
  2. Request urgent prescriber review with documented clinical justification for the combination
  3. Consider an independent medical examination if the prescriber cannot provide adequate justification
  4. Assess work capacity impact as the combination significantly increases sedation and impairment risk
  5. Document all interventions for audit trail and compliance purposes
  6. Check Reasonable and Necessary status for both medications against the compensable injury

Clinical reference

Moderate Regulator-flagged

A clinical summary of Mirtazapine and Clonazepam drawn from regulator advisories, national guidelines, and authoritative drug references. Read this if you want the deeper clinical picture before talking to your prescriber or pharmacist.

Severity assessment

Moderate. Concomitant use significantly increases the risk of central nervous system (CNS) depression, leading to enhanced sedation, dizziness, and impaired psychomotor function.

Mechanism (plain English)

Both clonazepam and mirtazapine affect the brain's chemical messengers, leading to a calming effect. Clonazepam, a benzodiazepine, works by enhancing the activity of gamma-aminobutyric acid (GABA), a neurotransmitter that reduces brain activity. Mirtazapine, an antidepressant, works by increasing the levels of certain neurotransmitters like noradrenaline and serotonin in the brain, but also has strong antihistaminic properties. When taken together, their combined sedative effects on the central nervous system are additive, meaning they can intensify each other, leading to increased drowsiness, slowed thinking, and reduced coordination.

Evidence level

Regulator-flagged. Both the FDA label for clonazepam and the MHRA Summary of Product Characteristics for mirtazapine explicitly warn about additive CNS depressant effects when co-administered with other CNS depressants, including benzodiazepines.

Top regulator advisories (cite verbatim or close paraphrase)

  • TGA (Australia): No pair-specific public advisory found. Applicable product information for mirtazapine (e.g., MIRTAZAPINE SANDOZ) would generally advise caution with other CNS depressants due to additive effects. Similarly, clonazepam product information would advise caution with other CNS depressants.
  • MHRA / NICE (UK): The MHRA Summary of Product Characteristics for mirtazapine states: "Mirtazapine may increase the sedating properties of benzodiazepines and other sedatives (notably most antipsychotics, antihistamine H1 antagonists, opioids). Caution should be exercised when these medicinal products are prescribed together with Mirtazapine." [1]
  • FDA / CDC (US): The FDA label for clonazepam advises: "Do not drink alcohol or take other drugs that may make you sleepy or dizzy while taking clonazepam until you talk to your healthcare provider. When taken with alcohol or drugs that cause sleepiness or dizziness, clonazepam tablets may make your sleepiness or dizziness worse." [2] The FDA also issues a Boxed Warning for benzodiazepines regarding concomitant use with opioids due to additive CNS depression, which highlights the general concern with combining CNS depressants.
  • EMA (Europe): The European Medicines Agency (EMA) would typically align with the MHRA SPC regarding the additive sedative effects of mirtazapine with benzodiazepines.

Clinical risk factors that elevate the danger

  • Elderly patients: More susceptible to CNS depressant effects, increasing risk of falls, confusion, and cognitive impairment.
  • Patients with respiratory compromise: Increased risk of respiratory depression.
  • Patients with hepatic or renal impairment: May have reduced clearance of one or both drugs, leading to higher drug levels and increased side effects.
  • Concomitant use of other CNS depressants: Including alcohol, opioids, antihistamines, or other sedatives, further exacerbating sedation.
  • High doses of either medication: Increases the likelihood and severity of CNS depression.
  • Rapid dose escalation: Does not allow the body to adjust to the sedative effects.

What a patient should be told

  • You may experience increased drowsiness, dizziness, and difficulty concentrating when taking clonazepam and mirtazapine together. This can affect your ability to drive or operate machinery safely.
  • Do not stop taking either medication suddenly without talking to your doctor or pharmacist, as this can lead to serious withdrawal symptoms or worsening of your condition.
  • Be aware of warning signs such as extreme sleepiness, confusion, slow or shallow breathing, or difficulty waking up. If these occur, seek immediate medical attention.
  • Discuss all other medications, supplements, and alcohol consumption with your prescriber or pharmacist to ensure safe use.
  • If you experience severe dizziness, extreme sedation, or trouble breathing, seek urgent medical care immediately.

Top 3 sources (with full citation)

  1. MHRA Products. MIRTAZAPINE 45 MG FILM-COATED TABLETS Summary of Product Characteristics. Medicines and Healthcare products Regulatory Agency. https://mhraproducts4853.blob.core.windows.net/docs/49a19d0d939172415a261fd37bb3dffedac19385 (Accessed June 1, 2026).
  2. DailyMed. CLONAZEPAM tablet. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=31a7ed52-48a6-1c87-e054-00144ff88e88 (Accessed June 1, 2026).
  3. Drugs.com. Clonazepam + Mirtazapine: Can You Take Them Together?. https://www.drugs.com/drug-interactions/clonazepam-with-mirtazapine-703-0-1640-0.html (Accessed June 1, 2026).

Notes for the reviewing pharmacist

The interaction between clonazepam and mirtazapine is primarily pharmacodynamic, resulting in additive CNS depression. While not typically considered a contraindication, the combination necessitates careful patient monitoring, especially during initiation or dose adjustments. The risk of serotonin syndrome is low with this specific combination as clonazepam is not a serotonergic agent. However, vigilance for signs of excessive sedation and respiratory depression is crucial. Consider patient-specific factors such as age, comorbidities (e.g., respiratory disease, hepatic/renal impairment), and concomitant medications that also cause CNS depression. Patient education should emphasize the importance of avoiding alcohol and other sedatives, recognizing symptoms of excessive sedation, and adhering strictly to prescribed dosages. Gradual tapering is essential if discontinuation of either agent is planned.

Source metadata JSON

{
  "pair": "clonazepam + mirtazapine",
  "severity": "Moderate",
  "evidence_level": "Regulator-flagged",
  "source_urls": "https://mhraproducts4853.blob.core.windows.net/docs/49a19d0d939172415a261fd37bb3dffedac19385;https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=31a7ed52-48a6-1c87-e054-00144ff88e88;https://www.drugs.com/drug-interactions/clonazepam-with-mirtazapine-703-0-1640-0.html"
}

Check this medication against your full medication list

Check all interactions for Mirtazapine and Clonazepam across your claimant's full medication list.

Allmeds AI Pharmacist scans interactions, schedules, and risk flags across your entire medication profile in minutes. Free for individuals; team plans for case managers, insurers, and schemes.

Related Resources

Important: This page is general health information, not personal medical advice. If you have questions about your medication — including starting it, stopping it, changing the dose, or combining it with something else — speak with your doctor or pharmacist. For an emergency or suspected overdose, call your local emergency number or poison information service immediately. Information is drawn from regulator and clinical guideline sources (TGA, FDA, MHRA, NICE, PBS, CDC); see our methodology for details.